INMODE LTD. (INMD): Price and Financial Metrics


INMODE LTD. (INMD): $26.64

0.64 (+2.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

INMD POWR Grades


  • INMD scores best on the Quality dimension, with a Quality rank ahead of 98.85% of US stocks.
  • INMD's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • INMD's current lowest rank is in the Stability metric (where it is better than 5.72% of US stocks).

INMD Stock Summary

  • The ratio of debt to operating expenses for InMode Ltd is higher than it is for about merely 7.35% of US stocks.
  • With a year-over-year growth in debt of 823.74%, InMode Ltd's debt growth rate surpasses 98.2% of about US stocks.
  • In terms of volatility of its share price, INMD is more volatile than 93.93% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to InMode Ltd, a group of peers worth examining would be HAYN, SHYF, SREV, AMRN, and CDXC.
  • INMD's SEC filings can be seen here. And to visit InMode Ltd's official web site, go to www.inmodemd.com.

INMD Valuation Summary

  • In comparison to the median Healthcare stock, INMD's price/earnings ratio is 14.79% higher, now standing at 41.9.
  • INMD's EV/EBIT ratio has moved up 23.5 over the prior 25 months.
  • Over the past 25 months, INMD's price/sales ratio has gone up 14.3.

Below are key valuation metrics over time for INMD.

Stock Date P/S P/B P/E EV/EBIT
INMD 2021-08-31 18.6 16.1 41.9 40.8
INMD 2021-08-30 18.9 16.4 42.6 41.5
INMD 2021-08-27 18.5 16.0 41.6 40.6
INMD 2021-08-26 17.9 15.5 40.3 39.2
INMD 2021-08-25 17.6 15.3 39.7 38.7
INMD 2021-08-24 17.5 15.2 39.5 38.5

INMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INMD has a Quality Grade of A, ranking ahead of 95.1% of graded US stocks.
  • INMD's asset turnover comes in at 0.881 -- ranking 27th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows INMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.881 0.853 0.578
2021-06-30 0.892 0.851 0.588
2021-03-31 0.808 0.850 0.517
2020-12-31 0.795 0.850 0.460
2020-09-30 0.741 0.852 0.383
2020-06-30 0.723 0.861 0.363

INMD Price Target

For more insight on analysts targets of INMD, see our INMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $123.80 Average Broker Recommendation 1.3 (Strong Buy)

INMD Stock Price Chart Interactive Chart >

Price chart for INMD

INMD Price/Volume Stats

Current price $26.64 52-week high $99.27
Prev. close $26.00 52-week low $20.60
Day low $26.38 Volume 2,607,081
Day high $27.62 Avg. volume 2,142,866
50-day MA $29.88 Dividend yield N/A
200-day MA $56.55 Market Cap 2.22B

INMODE LTD. (INMD) Company Bio


InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.


INMD Latest News Stream


Event/Time News Detail
Loading, please wait...

INMD Latest Social Stream


Loading social stream, please wait...

View Full INMD Social Stream

Latest INMD News From Around the Web

Below are the latest news stories about InMode Ltd that investors may wish to consider to help them evaluate INMD as an investment opportunity.

10 Biotech Stocks to Sell Now According to Cathie Wood

In this article, we discuss 10 biotech stocks to sell now according to Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to 5 Biotech Stocks to Sell Now According to Cathie Wood. The mass sell-off of stocks in the high growth sector has not been very kind to […]

Yahoo | February 22, 2022

7 Hot Stocks to Buy for a Cold Market

Investors are scared of inflation and rising interest rates, but these hot stocks have done well for awhile and should continue to do so.

Larry Ramer on InvestorPlace | February 14, 2022

Best Growth Stocks to Buy Now for February 2022

Growth stocks have been hit hard in 2022 due to fears of rising interest rates and high inflation. But that doesn’t mean growth investing is dead – far from it. There are still growth opportunities out there!

Yahoo | February 14, 2022

InMode Stock: Attractively Priced, Following Decline

InMode Ltd. (INMD) is a leading developer and supplier of innovative, energy-based, minimally-invasive surgical medical treatment solutions globally. Within the aesthetics market, InMode’s products and solutions are primarily developed to handle three energy-based therapy kinds, including (i) face and body contouring; (ii) medical esthetics; and (iii) women’s health. The company’s visionary products have constantly been at the forefront of technological evolution in the aesthetic solutions marke

Yahoo | February 13, 2022

Needham Keeps Their Buy Rating on InMode (INMD)

E ratio of 28.75.

Howard Kim on TipRanks | February 10, 2022

Read More 'INMD' Stories Here

INMD Price Returns

1-mo 2.30%
3-mo -39.05%
6-mo -68.29%
1-year -37.75%
3-year N/A
5-year N/A
YTD -62.26%
2021 197.30%
2020 21.12%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7518 seconds.